85 related articles for article (PubMed ID: 15651079)
1. Stimulation of Epstein-Barr virus-infected human B cell growth by physiological concentrations of 4-hydroxynonenal.
Ranjan D; Chen C; Johnston TD; Jeon H; Ibrahim M; Drake J; Butterfield DA
Cell Biochem Funct; 2006; 24(2):147-52. PubMed ID: 15651079
[TBL] [Abstract][Full Text] [Related]
2. Vitamin E inhibits cyclosporin A and H2O2 promoted Epstein-Barr virus (EBV) transformation of human B cells as assayed by EBV oncogene LMP1 expression.
Chen C; Reddy KS; Johnston TD; Khan TT; Ranjan D
J Surg Res; 2003 Aug; 113(2):228-33. PubMed ID: 12957134
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporin A-induced lipid and protein oxidation in human B-cells and in Epstein-Barr virus-infected B-cells is prevented by antioxidants.
Chen C; Jeon H; Johnston TD; Gedaly R; McHugh PP; Ranjan D
J Invest Surg; 2008; 21(4):201-8. PubMed ID: 18615317
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporine directly causes oxidative stress and promotes Epstein-Barr virus transformation of human B cells.
Chen C; Johnston TD; Reddy KS; Merrick JC; Mastrangelo M; Ranjan D
J Surg Res; 2001 Oct; 100(2):166-70. PubMed ID: 11592787
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin A up-regulates and activates protein kinase C-zeta in EBV-infected and EBV-transformed human B-cells.
Chen C; Johnston TD; Jeon H; Gedaly R; McHugh P; Ranjan D
J Surg Res; 2009 May; 153(1):156-61. PubMed ID: 18486150
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine promotes epstein-barr virus-infected human B-cell transformation assayed by three correlated assay methods.
Chen C; Johnston TD; Jeon H; Gedaly R; McHugh P; Ranjan D
Transplant Proc; 2009; 41(1):366-70. PubMed ID: 19249558
[TBL] [Abstract][Full Text] [Related]
7. Triptolide inhibits proliferation of Epstein-Barr virus-positive B lymphocytes by down-regulating expression of a viral protein LMP1.
Zhou H; Guo W; Long C; Wang H; Wang J; Sun X
Biochem Biophys Res Commun; 2015 Jan; 456(3):815-20. PubMed ID: 25511707
[TBL] [Abstract][Full Text] [Related]
8. [Epstein-Barr Virus LMP1 oncogene variants in cell lines of different origin].
Yakovleva LS; Senyuta NB; Goncharova EV; Scherback LN; Smirnova RV; Pavlish OA; Gurtsevitch VE
Mol Biol (Mosk); 2015; 49(5):800-10. PubMed ID: 26510598
[TBL] [Abstract][Full Text] [Related]
9. Effect of cyclosporine and tacrolimus on the growth of Epstein-Barr virus-transformed B-cell lines.
Beatty PR; Krams SM; Esquivel CO; Martinez OM
Transplantation; 1998 May; 65(9):1248-55. PubMed ID: 9603175
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 and Epstein-Barr virus induction by cyclosporine A: potential role in lymphoproliferative disease.
Tanner JE; Menezes J
Blood; 1994 Dec; 84(11):3956-64. PubMed ID: 7949151
[TBL] [Abstract][Full Text] [Related]
11. Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.
Lai KY; Chou YC; Lin JH; Liu Y; Lin KM; Doong SL; Chen MR; Yeh TH; Lin SJ; Tsai CH
J Virol; 2015 Jun; 89(11):5968-80. PubMed ID: 25810549
[TBL] [Abstract][Full Text] [Related]
12. The effect of curcumin on human B-cell immortalization by Epstein-Barr virus.
Ranjan D; Siquijor A; Johnston TD; Wu G; Nagabhuskahn M
Am Surg; 1998 Jan; 64(1):47-51; discussion 51-2. PubMed ID: 9457037
[TBL] [Abstract][Full Text] [Related]
13. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
[TBL] [Abstract][Full Text] [Related]
14. The Latent Membrane Protein 1 (LMP1).
Kieser A; Sterz KR
Curr Top Microbiol Immunol; 2015; 391():119-49. PubMed ID: 26428373
[TBL] [Abstract][Full Text] [Related]
15. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.
Rea D; Fourcade C; Leblond V; Rowe M; Joab I; Edelman L; Bitker MO; Gandjbakhch I; Suberbielle C; Farcet JP
Transplantation; 1994 Aug; 58(3):317-24. PubMed ID: 8053055
[TBL] [Abstract][Full Text] [Related]
16. Identification of rare Epstein-Barr virus infected memory B cells and plasma cells in non-monomorphic post-transplant lymphoproliferative disorders and the signature of viral signaling.
Shaknovich R; Basso K; Bhagat G; Mansukhani M; Hatzivassiliou G; Murty VV; Buettner M; Niedobitek G; Alobeid B; Cattoretti G
Haematologica; 2006 Oct; 91(10):1313-20. PubMed ID: 17018379
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor.
Kilger E; Kieser A; Baumann M; Hammerschmidt W
EMBO J; 1998 Mar; 17(6):1700-9. PubMed ID: 9501091
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.
Rasul AE; Nagy N; Sohlberg E; Ádori M; Claesson HE; Klein G; Klein E
J Immunol Methods; 2012 Nov; 385(1-2):60-70. PubMed ID: 22921685
[TBL] [Abstract][Full Text] [Related]
19. Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines.
Floettmann JE; Ward K; Rickinson AB; Rowe M
Virology; 1996 Sep; 223(1):29-40. PubMed ID: 8806537
[TBL] [Abstract][Full Text] [Related]
20. Multiple roles of LMP1 in Epstein-Barr virus induced immune escape.
Middeldorp JM; Pegtel DM
Semin Cancer Biol; 2008 Dec; 18(6):388-96. PubMed ID: 19013244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
